ENSTRUX trademark registration was filed on December 7, 2016, and the mark was successfully registered with the EUIPO on August 28, 2017 under EUTM trademark no. 016142127.
Novartis AG, who is the trademark holder was represented by MILOJEVIC, SEKULIC & ASSOCIATES, S.L. (EUIPO registered representative, ID no. 72057).
There were no raised oppositions across the publication period. The 90 day opposition period for this mark starts on May 19, 2017.
Expiration date for the current trademark registration is December 7, 2026.
|Trademark Name||ENSTRUX||Trademark No.||016142127|
|Filling Date||December 7, 2016||Registration Date||August 28, 2017|
|Reference||TMA026175-EM-CM03||Status Date||August 28, 2017|
|Legal Status||Legal entity|
|Address||Novartis Pharma AG
|Representative||MILOJEVIC, SEKULIC & ASSOCIATES, S.L.|
|Legal Status||Legal person|
|Address||Milojevic, Sekulic & Associates, S.L.
Dr. Severo Ochoa num.3, Bl.IV, P.2, 1-D
E-03550 San Juan (ALICANTE)
Pharmaceutical, Veterinary Products, Dietetic
Pharmaceutical preparations, vaccins, diagnostic preparations for medical use.
Disclaimer: The information provided on this page is considered public information by the European Union Intellectual Property Office and is provided for informational purposes only. It should not be construed as legal advice on any subject matter.